HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Eisenhut Selected Research

Experimental Liver Neoplasms

1/2007Polyamine-substituted gadolinium chelates: a new class of intracellular contrast agents for magnetic resonance imaging of tumors.
9/2006Troponin I overexpression inhibits tumor growth, perfusion, and vascularization of morris hepatoma.
9/2006Angiopoietin-2 overexpression in morris hepatoma results in increased tumor perfusion and induction of critical angiogenesis-promoting genes.
3/2006Angiostatin overexpression in Morris hepatoma results in decreased tumor growth but increased perfusion and vascularization.
10/2005Alkylating benzamides with melanoma cytotoxicity: role of melanin, tyrosinase, intracellular pH and DNA interaction.
5/2005Effects of Pax8 and TTF-1 thyroid transcription factor gene transfer in hepatoma cells: imaging of functional protein-protein interaction and iodide uptake.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Eisenhut Research Topics

Disease

53Neoplasms (Cancer)
04/2020 - 04/2003
17Prostatic Neoplasms (Prostate Cancer)
01/2020 - 01/2005
12Tuberculosis (Tuberculoses)
01/2020 - 10/2009
11Infections
07/2020 - 05/2004
11Pulmonary Edema
01/2020 - 03/2006
8Melanoma (Melanoma, Malignant)
11/2019 - 12/2002
8Sepsis (Septicemia)
03/2018 - 03/2006
7Malaria
05/2014 - 05/2005
7Hepatocellular Carcinoma (Hepatoma)
08/2010 - 10/2004
6Carcinoma (Carcinomatosis)
08/2010 - 03/2002
6Experimental Liver Neoplasms
01/2007 - 05/2005
5Communicable Diseases (Infectious Diseases)
01/2020 - 05/2005
5Inflammation (Inflammations)
01/2019 - 04/2011
5Acute Lung Injury
06/2011 - 08/2006
4Breast Neoplasms (Breast Cancer)
01/2020 - 09/2005
4Pulmonary Tuberculosis
01/2020 - 10/2009
4Intracranial Vasospasm
01/2018 - 12/2012
4Lung Injury
10/2012 - 12/2006
4Falciparum Malaria (Plasmodium falciparum Malaria)
12/2010 - 05/2005
3Septic Shock (Toxic Shock Syndrome)
06/2020 - 09/2006
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2019 - 07/2006
3Meningitis
01/2019 - 08/2003
3Brain Injuries (Brain Injury)
01/2019 - 01/2017
3Pyelonephritis
01/2018 - 03/2006
3Edema (Dropsy)
01/2017 - 01/2006
3Neoplasm Metastasis (Metastasis)
05/2014 - 07/2006
3Hepatitis
01/2013 - 05/2004
3Cerebral Malaria
12/2012 - 05/2007
3Thyroid Neoplasms (Thyroid Cancer)
11/2012 - 05/2004
3Experimental Melanoma
12/2006 - 10/2004
2Supraventricular Tachycardia
01/2022 - 01/2006
2COVID-19
01/2022 - 01/2020
2Purpura
05/2020 - 10/2017
2Vasculitis (Vasculitides)
05/2020 - 02/2019
2IgA Vasculitis (Purpura, Schoenlein Henoch)
05/2020 - 10/2017
2Hypersensitivity (Allergy)
05/2020 - 04/2011
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2020 - 05/2007
2Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2020 - 03/2011
2Lung Diseases (Lung Disease)
01/2020 - 01/2007
2Autoimmune Diseases (Autoimmune Disease)
01/2019 - 06/2018
2Necrosis
01/2019 - 12/2011
2Hypovolemia
12/2018 - 03/2006
2Hyponatremia
11/2018 - 03/2006
2Rheumatic Diseases (Rheumatism)
07/2018 - 03/2018

Drug/Important Bio-Agent (IBA)

15Peptides (Polypeptides)IBA
08/2013 - 04/2003
12LigandsIBA
01/2017 - 12/2002
12AntigensIBA
10/2016 - 01/2007
11CytokinesIBA
01/2020 - 12/2006
7Glucose (Dextrose)FDA LinkGeneric
12/2018 - 03/2002
7Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2017 - 05/2007
6SodiumIBA
01/2020 - 01/2006
6InterferonsIBA
11/2019 - 01/2013
6N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
08/2017 - 04/2012
6BenzamidesIBA
01/2014 - 12/2002
6Radioisotopes (Radionuclides)IBA
01/2014 - 04/2005
5AntibodiesIBA
07/2020 - 11/2009
5Pharmaceutical PreparationsIBA
01/2020 - 03/2009
5Biomarkers (Surrogate Marker)IBA
11/2019 - 01/2016
5gallium 68 PSMA-11IBA
08/2017 - 10/2013
5Interferon-gamma (Interferon, gamma)IBA
03/2015 - 02/2008
51,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
04/2013 - 05/2005
4InflammasomesIBA
01/2019 - 01/2017
4Proteins (Proteins, Gene)FDA Link
03/2018 - 05/2005
4CalciumIBA
01/2017 - 04/2011
4RadiopharmaceuticalsIBA
01/2017 - 09/2005
4benzamideIBA
01/2014 - 12/2002
4Melanins (Melanin)IBA
01/2014 - 10/2005
4IntegrinsIBA
11/2011 - 02/2007
4BombesinIBA
02/2011 - 04/2005
3Immunoglobulin G (IgG)IBA
07/2020 - 01/2007
3SteroidsIBA
05/2020 - 01/2018
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020 - 01/2014
3ChloridesIBA
01/2020 - 03/2006
3Rituximab (Mabthera)FDA Link
11/2019 - 02/2014
3VaccinesIBA
06/2019 - 01/2007
3Interleukin-1 (Interleukin 1)IBA
01/2019 - 01/2017
3Urea (Carbamide)FDA LinkGeneric
11/2018 - 04/2012
3C-Reactive ProteinIBA
03/2018 - 01/2008
3Bombesin Receptors (Bombesin Receptor)IBA
05/2014 - 04/2005
3AcidsIBA
11/2012 - 08/2007
3Edotreotide (SMT 487)IBA
09/2012 - 07/2006
3Anti-Bacterial Agents (Antibiotics)IBA
08/2011 - 08/2003
3IodidesIBA
12/2010 - 05/2004
3Biological ProductsIBA
11/2009 - 05/2005
3Quinine (Quinson)FDA Link
01/2009 - 05/2005
3DNA (Deoxyribonucleic Acid)IBA
09/2006 - 03/2005
3Tyrosine (L-Tyrosine)FDA Link
04/2004 - 03/2002
2Transcription Factors (Transcription Factor)IBA
06/2020 - 05/2005
2Immunoglobulin A (IgA)IBA
05/2020 - 10/2017
2DapsoneFDA Link
05/2020 - 10/2017
2MicroRNAs (MicroRNA)IBA
04/2020 - 04/2017
2Vitamin DFDA LinkGeneric
01/2020 - 10/2009
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 08/2007
2Rifampin (Rifampicin)FDA LinkGeneric
01/2020 - 03/2011
2Monoclonal AntibodiesIBA
11/2019 - 01/2016
2Nitric Oxide DonorsIBA
01/2019 - 10/2015

Therapy/Procedure

25Therapeutics
11/2019 - 03/2002
6Drug Therapy (Chemotherapy)
11/2019 - 12/2006
4Radiotherapy
09/2012 - 11/2002
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2019 - 11/2018